John N. Constantino is a board-certified child and adolescent psychiatrist and chief of behavioral and mental Health at Children’s Healthcare of Atlanta, as well as professor of psychiatry and pediatrics at Emory University School of Medicine. He is an international leader in autism trait phenotyping, sex differences in autism, and endophenotypic analyses.
John Constantino
Chief of behavioral and mental health
Children’s Healthcare of Atlanta
From this contributor
Autism is more heritable in boys than in girls
If boys have greater inherited liability for autism, the female protective effect may not fully explain the sex difference in prevalence.
Autism is more heritable in boys than in girls
Q&A with John Constantino: Solving the biomarker conundrum
Biological factors that reflect autism’s roots may differ from those that influence how severe the condition is. Failure to make a distinction has stymied the search for biomarkers.
Q&A with John Constantino: Solving the biomarker conundrum
Traits of other conditions may spur autism
Early features of other conditions may contribute to autism itself
Traits of other conditions may spur autism
Japanese spectrum
Researchers studying autism prevalence should take into account the continuous nature of autism symptoms in the general population, says John Constantino.
Explore more from The Transmitter
From friend to foe: How the brain updates feelings toward others
A specific hippocampus-to-amygdala pathway reassigns emotional valence to a known individual, whereas the hippocampus’s own representation of that individual’s identity remains stable.
From friend to foe: How the brain updates feelings toward others
A specific hippocampus-to-amygdala pathway reassigns emotional valence to a known individual, whereas the hippocampus’s own representation of that individual’s identity remains stable.
Mass-produced science is coming. What happens to scientists?
Artificial intelligence may soon enable researchers to generate high-quality science at a previously unimaginable speed. For science consumers—the public, medical patients, technology users—the likely effects will be positive. For scientists, the effects will be as disruptive as industrial mass production was for artisan manufacturers.
Mass-produced science is coming. What happens to scientists?
Artificial intelligence may soon enable researchers to generate high-quality science at a previously unimaginable speed. For science consumers—the public, medical patients, technology users—the likely effects will be positive. For scientists, the effects will be as disruptive as industrial mass production was for artisan manufacturers.
Neuropathologist not guilty of research misconduct, says university probe
The investigation determined that seven papers by corresponding author Adriano Aguzzi have “scientifically significant” errors, which Aguzzi attributes to his former students.
Neuropathologist not guilty of research misconduct, says university probe
The investigation determined that seven papers by corresponding author Adriano Aguzzi have “scientifically significant” errors, which Aguzzi attributes to his former students.